v3.25.2
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY - USD ($)
shares in Millions, $ in Millions
Total
Common Stock
Additional Paid-In Capital
Treasury Stock
Accumulated Other Comprehensive (Loss) Income
Retained Earnings
Beginning balance (in shares) at Dec. 31, 2023   408.1        
Beginning balance at Dec. 31, 2023 $ 7,338.6 $ 4.1 $ 5,147.8   $ (17.6) $ 2,204.3
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) 6.7         6.7
Other comprehensive income (loss) (4.3)       (4.3)  
Restricted stock grants (in shares)   1.4        
Restricted stock grants surrendered (in shares)   (0.4)        
Restricted stock grants surrendered (24.5)   (24.5)      
Employee stock purchase plan (in shares)   0.1        
Employee stock purchase plan 5.2   5.2      
Management stock purchase plan (1.5)   (1.5)      
Stock-based compensation expense 22.4   22.4      
Ending balance (in shares) at Mar. 31, 2024   409.2        
Ending balance at Mar. 31, 2024 7,342.6 $ 4.1 5,149.4   (21.9) 2,211.0
Beginning balance (in shares) at Dec. 31, 2023   408.1        
Beginning balance at Dec. 31, 2023 7,338.6 $ 4.1 5,147.8   (17.6) 2,204.3
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) 25.9          
Other comprehensive income (loss) (4.5)          
Ending balance (in shares) at Jun. 30, 2024   409.3        
Ending balance at Jun. 30, 2024 7,395.7 $ 4.1 5,183.5   (22.1) 2,230.2
Beginning balance (in shares) at Mar. 31, 2024   409.2        
Beginning balance at Mar. 31, 2024 7,342.6 $ 4.1 5,149.4   (21.9) 2,211.0
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) 19.2         19.2
Other comprehensive income (loss) (0.2)       (0.2)  
Exercise of stock options (in shares)   0.1        
Exercise of stock options 7.1   7.1      
Restricted stock grants (in shares)   0.1        
Restricted stock grants surrendered (in shares)   (0.2)        
Restricted stock grants surrendered (0.7)   (0.7)      
Employee stock purchase plan (in shares)   0.1        
Employee stock purchase plan 6.0   6.0      
Management stock purchase plan (0.2)   (0.2)      
Stock-based compensation expense 21.9   21.9      
Ending balance (in shares) at Jun. 30, 2024   409.3        
Ending balance at Jun. 30, 2024 7,395.7 $ 4.1 5,183.5   (22.1) 2,230.2
Beginning balance (in shares) at Dec. 31, 2024   409.5        
Beginning balance at Dec. 31, 2024 7,553.5 $ 4.1 5,231.9 $ 0.0 (25.5) 2,343.0
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) (14.8)         (14.8)
Other comprehensive income (loss) 8.8       8.8  
Exercise of stock options (in shares)   0.1        
Exercise of stock options 0.9   0.9      
Restricted stock grants (in shares)   2.3        
Restricted stock grants surrendered (in shares)   (0.3)        
Restricted stock grants surrendered (33.4)   (33.4)      
Employee stock purchase plan (in shares)   0.1        
Employee stock purchase plan 6.3   6.3      
Management stock purchase plan (1.3)   (1.3)      
Stock-based compensation expense 29.7   29.7      
Stock repurchases under stock repurchase programs (0.6 million shares) (18.5)     (18.5)    
Common stock issued for Matterport Acquisition (in shares)   11.7        
Common stock issued for Matterport Acquisition 1,025.0 $ 0.1 1,024.9      
Ending balance (in shares) at Mar. 31, 2025   423.4        
Ending balance at Mar. 31, 2025 8,556.2 $ 4.2 6,259.0 (18.5) (16.7) 2,328.2
Beginning balance (in shares) at Dec. 31, 2024   409.5        
Beginning balance at Dec. 31, 2024 7,553.5 $ 4.1 5,231.9 0.0 (25.5) 2,343.0
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) (8.6)          
Other comprehensive income (loss) 45.7          
Stock repurchases under stock repurchase programs (0.6 million shares)       (63.8)    
Ending balance (in shares) at Jun. 30, 2025   424.1        
Ending balance at Jun. 30, 2025 8,601.4 $ 4.2 6,306.4 (63.8) 20.2 2,334.4
Beginning balance (in shares) at Mar. 31, 2025   423.4        
Beginning balance at Mar. 31, 2025 8,556.2 $ 4.2 6,259.0 (18.5) (16.7) 2,328.2
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) 6.2         6.2
Other comprehensive income (loss) 36.9       36.9  
Exercise of stock options (in shares)   0.4        
Exercise of stock options 3.7   3.7      
Restricted stock grants (in shares)   0.3        
Restricted stock grants surrendered (in shares)   (0.1)        
Restricted stock grants surrendered (11.9)   (11.9)      
Employee stock purchase plan (in shares)   0.1        
Employee stock purchase plan 4.5   4.5      
Management stock purchase plan (0.4)   (0.4)      
Stock-based compensation expense 51.5   51.5      
Stock repurchases under stock repurchase programs (0.6 million shares) (45.3)     (45.3)    
Ending balance (in shares) at Jun. 30, 2025   424.1        
Ending balance at Jun. 30, 2025 $ 8,601.4 $ 4.2 $ 6,306.4 $ (63.8) $ 20.2 $ 2,334.4